ComplianceAnalysis

FMCSA Revokes 80th ELD Device: Mid-Year DOT Compliance Status Check for Motor Carriers

FMCSA removed TRUCKSTAFF ELD on June 23, 2026 — the 80th device revoked since January 2025. Combined with the new observed collection rule and a pending fentanyl testing mandate, here is what carriers must address before the second half of 2026.

Michael Torres
By Michael Torres
DOT Compliance, Drug Testing, and Transportation Safety Contributor · · 10 min read
Fact-checked

The Federal Motor Carrier Safety Administration (FMCSA) removed TRUCKSTAFF ELD from its list of registered electronic logging devices on June 23, 2026. The device failed to meet minimum technical requirements under 49 CFR Part 395, Appendix A to Subpart B. It is the 80th ELD revocation since January 2025 — a pace that signals FMCSA is far from finished cleaning up the device ecosystem.

But the ELD purge is only one front in a broader enforcement posture that motor carriers must reckon with as the second half of 2026 begins. The new DOT observed collection rule took effect June 10. The fentanyl testing panel addition is still pending but expected imminently. And with over 202,000 CDL holders sitting in prohibited status in the FMCSA Drug & Alcohol Clearinghouse, the compliance landscape has never demanded more active management from fleet operators.

Here is what carriers need to know — and do — right now.

TRUCKSTAFF ELD Revocation: The 80th Device Down

FMCSA's June 23 announcement continues an aggressive device-compliance initiative that has accelerated sharply since early 2025. The agency has now revoked 80 devices in roughly 18 months, compared to fewer than a dozen in the several years preceding.

What Carriers Using TRUCKSTAFF Must Do

The compliance timeline is straightforward but unforgiving:

  1. Immediately stop relying on TRUCKSTAFF ELD for regulatory hours-of-service (HOS) recordkeeping.
  2. Revert to paper logs or compliant logging software to document driver duty status during the transition period.
  3. Install a replacement ELD from the FMCSA registered devices list no later than August 23, 2026 — the 60-day deadline.
  4. Retain all data from the TRUCKSTAFF device for the required six-month retention period under 49 CFR 395.8.

After August 23, any driver still using TRUCKSTAFF will be treated as having no record of duty status. Under CVSA out-of-service criteria, that driver will be placed out of service immediately during a roadside inspection. Carriers face civil penalties of up to $19,246 per violation under current inflation-adjusted schedules.

Why the Revocation Rate Matters

The 80-device milestone is significant because it reflects a structural shift in how FMCSA views the ELD marketplace. The agency has made clear that registration does not equal permanent approval — devices must continuously meet technical specifications for data recording, display, transfer, and self-compliance monitoring.

For fleet managers, the lesson is operational: verify your ELD's registration status regularly. A device that was compliant when you purchased it can be pulled at any time if the manufacturer fails to maintain federal standards. FMCSA maintains both a registered devices list and a revoked devices list that carriers should check monthly at minimum.

DOT Observed Collection Rule: Now in Effect

On June 10, 2026, a DOT final rule amending 49 CFR Part 40 took effect. The rule addresses a procedural gap that had existed since DOT authorized oral fluid testing in 2023: what happens when a directly observed urine collection is required but a same-sex observer is unavailable, and oral fluid testing does not yet exist as a fallback.

Key Provisions

  • When a same-sex observer is unavailable at the collection site and oral fluid testing is not yet available (no HHS-certified labs), the collector must contact the DER. The DER must then either locate a same-sex observer from another source or direct the employee to a different collection site that can perform the observed collection.
  • Oral fluid testing cannot be used until at least two laboratories receive HHS certification for DOT oral fluid analyses. As of June 2026, no such labs have been certified.
  • An 18-month grace period will begin once two labs are certified, giving employers time to implement oral fluid collection protocols.
  • Terminology update: The rule replaces "gender" with "sex" throughout Part 40, consistent with Executive Order 14168.

Action Items for DERs

If your organization conducts DOT-regulated drug testing, your DER procedures should already reflect the June 10 changes:

  • Update written policies and collection-site instructions to document the decision tree when a same-sex observer cannot be located.
  • Ensure collectors understand they must contact the DER — not make the decision independently — when an observer is unavailable.
  • Identify backup collection sites within your service area that can accommodate directly observed collections on short notice.
  • Monitor ODAPC announcements for lab certification updates that will trigger the 18-month oral fluid transition window.

Fentanyl Panel Addition: Still Pending, Still Critical

The DOT published a Notice of Proposed Rulemaking on September 2, 2025 (90 FR 42363), proposing to add fentanyl and its metabolite norfentanyl to the mandatory drug testing panel under 49 CFR Part 40. The public comment period closed October 17, 2025.

As of late June 2026, the final rule has not been published — but the regulatory machinery is in motion and publication is expected in 2026.

What the Rule Will Require

When finalized, the fentanyl addition will apply to all DOT-regulated testing — pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up. Key technical details from the NPRM include:

  • Initial test cutoff: 1 ng/mL for both urine and oral fluid
  • Confirmatory test cutoff: 0.5 ng/mL for both urine and oral fluid
  • Morphine cutoff increase: From 2,000 ng/mL to 4,000 ng/mL, aligning with updated HHS Mandatory Guidelines

The rationale is urgent. According to CDC data cited in the NPRM, synthetic opioids — primarily fentanyl — now account for approximately 70% of all U.S. overdose fatalities. The current DOT 5-panel test does not detect fentanyl unless specifically ordered, leaving a significant gap in safety-sensitive workforce screening.

Preparing Now

Carriers should not wait for the final rule to begin preparation:

  • Notify your testing laboratory and third-party administrator (TPA) that fentanyl panel testing is coming. Confirm they can process the new analytes.
  • Update your drug and alcohol policy template to reference the expanded panel. Build in effective-date language tied to Federal Register publication.
  • Brief supervisors and employees that the testing panel will expand. This is especially important for drivers who may be taking prescribed fentanyl patches or other legitimate medications — they will need to disclose prescriptions to the Medical Review Officer (MRO) upon a confirmed positive.

Clearinghouse Compliance: 202,000 Drivers in Prohibited Status

The FMCSA Drug & Alcohol Clearinghouse reported over 202,000 CDL and CLP holders in prohibited status as of early 2026. Approximately 159,000 of those drivers have not initiated the return-to-duty (RTD) process at all.

With Clearinghouse Phase II now fully operational in all 50 states, State Driver Licensing Agencies automatically downgrade the CDL of any driver in prohibited status. This means the licensing backstop that once allowed some prohibited drivers to continue operating by slipping through cracks between state and federal systems no longer exists.

Mid-Year Clearinghouse Checklist

  • Run full pre-employment queries on every new hire before allowing them to perform safety-sensitive functions.
  • Complete annual limited queries on all current CDL employees — this is a regulatory requirement, not optional.
  • Report violations within three business days of learning about a positive test, refusal to test, or actual knowledge of drug or alcohol use.
  • Verify RTD completion for any driver returning from prohibited status. Do not rely on the driver's self-reporting; obtain direct confirmation through the Clearinghouse portal.

Penalties for non-compliance remain steep: up to $7,500 for employing a prohibited driver and up to $6,000 for failure to report a violation.

What Employers Should Do Now: A Mid-Year Compliance Punch List

With six months of regulatory activity behind them, motor carriers should treat the end of June as a natural checkpoint. Here is a consolidated action list:

ELD Compliance

  • Verify every device in your fleet against the FMCSA registered ELD list
  • If using TRUCKSTAFF, execute replacement by August 23, 2026
  • Set a recurring monthly calendar event to recheck the registered/revoked ELD lists
  • Ensure backup paper log supplies are available at every terminal

Drug and Alcohol Testing

Clearinghouse

  • Audit that all required annual limited queries have been completed for the current year
  • Confirm no current drivers appear in prohibited status
  • Review internal reporting timelines to ensure the three-business-day window is being met

Documentation and Audit Readiness

  • Update your written drug and alcohol policy to reflect 2026 regulatory changes
  • Archive all driver qualification (DQ) files electronically — electronic DVIRs are now officially valid under 2026 FMCSA guidance
  • Prepare for potential DOT or state compliance audits by centralizing all HOS, testing, and DQ documentation

For carriers managing multi-location fleets, centralizing compliance documentation across terminals can significantly reduce the risk of missed deadlines and audit gaps. Resources like BlueHive's transportation compliance guides offer frameworks for scheduling, tracking, and reporting designed for DOT-regulated employers managing these overlapping requirements.

Looking Ahead: Second Half of 2026

The regulatory cadence is unlikely to slow. Based on current rulemaking timelines, carriers should anticipate:

  • Fentanyl final rule publication — expected to provide a compliance effective date likely 6–12 months after publication
  • Possible HHS oral fluid lab certifications — which will start the 18-month countdown for carriers to implement oral fluid testing as a collection option
  • Continued ELD revocations — FMCSA has shown no signs of easing its device-compliance enforcement
  • SMS scoring refinements — FMCSA's ongoing Safety Measurement System overhaul is expected to consolidate violation categories into a rolling 12-month model, placing greater weight on recent violations

Staying ahead of these changes requires active monitoring, not passive compliance. The carriers that will avoid enforcement actions and operational disruptions in 2026 are the ones treating compliance as a continuous function, not an annual checkbox exercise.

Sources

Tags

DOT complianceFMCSAELDelectronic logging devicedrug testingfentanyloral fluid testingtransportation safety49 CFR Part 4049 CFR Part 395

Frequently Asked Questions

As of June 23, 2026, FMCSA has revoked 80 electronic logging devices from its registered list since January 2025. The most recent revocation was TRUCKSTAFF ELD, which carriers must replace by August 23, 2026.

Carriers using TRUCKSTAFF ELD have until August 23, 2026 — 60 days from the June 23 revocation date — to transition to a compliant ELD. During the grace period, drivers must use paper logs or approved logging software.

Not yet. DOT published a proposed rule (90 FR 42363) in September 2025 to add fentanyl and norfentanyl to the testing panel, but the final rule has not been published as of June 2026. Employers must continue using the current 5-panel test until the final rule takes effect.

No. While DOT has authorized oral fluid testing under 49 CFR Part 40, it cannot be used until at least two HHS-certified oral fluid laboratories are operational. As of June 2026, no such labs have been certified. Employers must continue with urine-based testing.

Carriers should verify their ELD is still on the FMCSA registered list, ensure DER protocols comply with the June 10 observed collection rule, monitor for the fentanyl final rule publication, and run Clearinghouse queries on all current drivers to confirm none are in prohibited status.

Related Articles

Never Miss an Update

Join industry professionals who rely on our weekly compliance digest.